Adipo-neuroinflammation, cognitive impairment and surrogate markers of cardiovascular risk in patients with MASLD
European Atherosclerosis Journal · 30.04.2026 · 5 (1) · 22
DOI: 10.56095/eaj.v5i1.125 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Atherosclerosis Journal, online erschienen am 30.04.2026. Verfasst von Gaetano Pacinella und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
The epidemiological burden MASLD have been slowly increasing in recent years. Starting from a background of metabolic dysfunction, we evaluated the associations between adipo-neuroinflammation markers (LCN2), indicators of cognitive impairment (MMSE score), surrogate cardiovascular risk indicators (RHI, IMT and MMEE), and MASLD.
Methods
In this cross-sectional study, we enrolled a group of 40 patients with a recent diagnosis of MASLD and a control group of 40 patients with no history of liver disease.
Results
Compared with the controls, patients with MASLD had higher serum levels of LCN2, lower RHI and MMEE values, and lower MMSE scores; univariate analysis also revealed that the differences between the groups in terms of heart rate, body weight, body mass index, body surface area, glycated haemoglobin, and echocardiographic variables (interventricular septal thickness, LVPWT, EF, LAVI, and E/A ratio) were statistically significant. Multinomial regression revealed that the presence of MASLD was significantly positively associated with LVPWT and LCN2, and significantly negatively associated with the RHI. With regards to assessments of cognitive impairment, the presence of MASLD was significantly negatively associated with the MMSE score. We also performed ROC curve analysis to explore the ability of RHI to predict MASLD; the results yielded an AUC of 0.826 (95% CI: 0.72–0.90; p
Zitieren
APA
Pacinella, G., Cuore, A. D., Basso, M. G., Daidone, M., & Tuttolomondo, A. (2026). Adipo-neuroinflammation, cognitive impairment and surrogate markers of cardiovascular risk in patients with MASLD. European Atherosclerosis Journal, 5(1), 22. https://doi.org/10.56095/eaj.v5i1.125
Vancouver
Pacinella G, Cuore AD, Basso MG, Daidone M, Tuttolomondo A. Adipo-neuroinflammation, cognitive impairment and surrogate markers of cardiovascular risk in patients with MASLD. European Atherosclerosis Journal. 2026;5(1):22. doi:10.56095/eaj.v5i1.125
BibTeX
@article{Pacinella2026,
author = {Pacinella, Gaetano and Cuore, Alessandro Del and Basso, Maria Grazia and Daidone, Mario and Tuttolomondo, Antonino},
title = {Adipo-neuroinflammation, cognitive impairment and surrogate markers of cardiovascular risk in patients with MASLD},
journal = {European Atherosclerosis Journal},
year = {2026},
volume = {5},
number = {1},
pages = {22},
doi = {10.56095/eaj.v5i1.125}
}
EUVIMED